Length of time after re-transplantation Proportion of survival, %
(95% CI): Re-tx with VAD and PRVTXDIF <= 30 days
Proportion of survival, % (95% CI): Re-tx without VAD and PRVTXDIF <= 30 days Proportion of survival, %
(95% CI): Re-tx with VAD and PRVTXDIF > 30 days
Proportion of survival, %
(95% CI): Re-tx without VAD and PRVTXDIF > 30 days
1 year 33% (16%, 68%) 56% (40%, 79%) 93% (80%, 100%) 83% (81%, 86%)
2 years 27% (12%, 62%) 52% (36%, 76%) 85% (68%, 100%) 78% (75%, 81%)
3 years 27% (12%, 62%) 42% (26%, 68%) 85% (68%, 100%) 73% (70%, 76%)
4 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 70% (66%, 73%)
5 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 66% (62%, 70%)
6 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 62% (58%, 66%)
7 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 58% (54%, 62%)
8 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 55% (50%, 59%)
9 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 50% (46%, 55%)
10 years 27% (12%, 62%) 36% (21%, 63%) 85% (68%, 100%) 47% (43%, 52%)
PRVTXDIF= time difference between re-transplant and previous transplant. CI = confidence interval. VAD= ventricular assist device.
Table 2: Proportion of survival following re-transplantation according to VAD support and non- VAD support.